Main
>
ONCOLOGY (**)
>
Gastric Cancer>MET or R PD-L1+***
>
Treatment
>
USA. M. PembrolizuMAb>>
>
Companion Diagnostics>
>
>(*) USA Approval Date: 2017. 09.22
>(*) USA Approval Date: 2017. 09.22's products
This section has no products